ALMKT:EPA
Mauna Kea Technologies SA
0,14 €
0,00%
(0,00) 1D
30-сен., 17:35:19 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Mkt. cap
26,09 млн
Avg. vol.
416,28 миң
Volume
0,00
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
Mkt. cap
26,09 млн
Avg. vol.
416,28 миң
Volume
0,00
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
News stories
From web sources and news partners
Benzinga
·
8 мүнөт мурун
Dow Dips Over 400 Points Following PCE Data: Investor Sentiment Improves, Greed Index Remains in ‘Fear’ Z
TradingView
·
21 мүнөт мурун
IXIC: Nasdaq Wraps Up Q3 with a Gain as Traders Enter Q4 with Mixed Feelings
MarketBeat
·
33 мүнөт мурун
PLBY Group (NASDAQ:PLBY) Stock Price Down 0.5% - Time to Sell?
Investor's Business Daily
·
3 саат мурун
Dow Jones Futures: Micron Earnings Crush Views, S&P 500 At Critical Level As Treasury Yields Rise
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA